Cyclopharm Limited (AU:CYC) has released an update.
Cyclopharm Limited has announced that shareholders have passed all proposed resolutions at its recent Annual General Meeting, including the approval for a share buy-back, election of a new director, and adoption of a Loan Share Plan. While the share buy-back option has been approved, the company’s directors have no intention of executing this within the next 12 months. The company emphasized unanimous shareholder support with each resolution carried by an overwhelming majority.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.
